🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

@Alzheimersassoication published a new study that shows the drug development pipeline is advancing, but the need for efficient recruitment is vital. #ClinicalTrials Read here: bit.ly/3Njq7Rv

A study published in nature suggests demyelination may be a part of the pathology of #AlzheimersDisease (AD). This could be a promising target to delay the development of AD. Read more: bit.ly/3NtNfNn

Today the FDA granted fully approval for the use of #lecanemab (#Leqembi) to 1 million+ Medicare patients in the early stages of #Alzheimers. Click the image to hear what our CEO has to say about the news.

INmune Bio is excited to participate in #AAIC23! We will showcase two new abstracts and host an exhibitor booth, #213. We hope to see you next week in Amsterdam! 👋

Our CEO RJ Tesi was interviewed by Robert "Sully" Sullivan about how #neuroinflammation causes #AlzheimersDisease (AD) and INmuneBio's approach to creating treatments. Watch the full interview here: bit.ly/44rTp6l

#ICYMI our CEO Dr. RJ Tesi delivered the opening keynote presentation at the 5th World Aging and Rejuvenation Conference last week in Germany, speaking about drug development strategies to improve health span. Read more about this important topic here: bit.ly/3Dh7jwp

At last week's annual @Alzheimer's Association 2023 International Conference (#AAIC23), we were proud to announce new findings from data involving novel MRI biomarkers in participants from an open-label Phase 1b study. Read the full release here: bit.ly/46MYKa8

Our CEO Dr. RJ Tesi recently penned an article for Clinical Leader about why so many clinical trials for #Alzheimers have failed. Read his full piece here: bit.ly/3qeTfAx

Our CEO Dr. RJ Tesi has been featured in a recent Medical News Today article exploring the potential of CRISPR gene therapy in the treatment of #Alzheimers. Read the full article here: bit.ly/44Z8axt #INmuneBio #AlzheimersResearch #CRISPR #GeneTherapy #Neuroscience

#ICYMI, our CEO RJ Tesi spoke with @NeurologyLive during #AAIC23 about INmune Bio's recently-announced MRI biomarker data. Read more here: bit.ly/3OekdQT #Neurology #BrainHealth #Alzheimers #Innovation

Our CEO rj Tesi has been featured in a recent article from Verywell Health Health about recent evidence suggesting that elevated cholesterol levels could play a role in the progression and development of #Alzheimers. Click here to read more: bit.ly/47s5Cdx

Our CEO Dr. RJ Tesi was featured by @MedicalNewsToday in an article that discusses the potential of p38 inhibitors being used to treat #Alzheimers. Read the full story to hear his thoughts on the recent research. bit.ly/43KhEM6 #Neurology #BrainHealth #AD

Our CFO David Moss was featured in an article by KFF. David shares “A lot of clinicians are excited about the drug, and patients are hearing about it, it’s a money center for infusion centers and MRI operators.” Click here to read more: bit.ly/3YCnHBk

Our CEO Dr. RJ Tesi was featured in a recent Medical News Today article exploring a new blood-based biomarker test available for individuals to gauge their risk for developing Alzheimer’s. Read the full article here: bit.ly/3DRULMd #Neurology #BrainHealth #AlzheimersDisease

📢 We are pleased to announce our authorization of a Clinical Trial Application to initiate a Phase 2 trial in early Alzheimer’s disease with XPro™. Full release here: bit.ly/3sK1Z2J. #Alzheimers #AlzheimersDisease #ADtreatment

Our CFO David Moss has been featured in a recent CBS News article discussing the groundbreaking developments in #Alzheimers research and #healthcare economics. Read the full article to learn more about Alzheimer's research and healthcare economics: cbsn.ws/3OKgaxc

Another episode of INside INmune Bio is out! 🎥 Our CFO and host David Moss unravels the "master cytokine," tumor necrosis factor, with our CEO Dr. RJ Tesi. Watch the full episode here: bit.ly/47V0Cho

For #AlzheimersAwarenessMonth, Cumulus Neuroscience is honored to be sponsoring a webinar on Friday November 10th titled "Leveraging Digital Biomarkers to Generate Real-World Physiological and Behavioral Data in CNS Clinical Studies". #ENDALZ #CNS #neuroscience